Niger's HIV Response : Targeted Investments for a Healthy Future - Findings from the HIV Allocative Efficiency and Financial Sustainability Study (English)

Niger's morbidity and mortality statistics are dominated by communicable diseases while there is until now a relatively low burden of disease attributable to non-communicable diseases. Despite Niger being a low human immunodeficiency virus (HIV) prevalence and comparatively low HIV and acquired immunodeficiency syndrome (AIDS) burden country, HIV and AIDS is an emerging and significant cause of disability adjusted life year (DALYs) since recent years...

Document also available in : French

DETAILS

Author

Cheikh,Nejma;

Fraser-Hurt,Nicole;

Prestidge,Marelize;

Haacker,Markus;

Karamoko,Djibrilla;

Masaki,Emiko;
Document Date
2014/06/01
Document Type
Other Health Study
Report Number
AUS8114
Volume No
1
Total Volume(s)
1
Country
Niger,
Region
Western and Central Africa,
Disclosure Date
2019/10/17
Disclosure Status
Disclosed
Doc Name
Niger's HIV Response : Targeted Investments for a Healthy Future - Findings from the HIV Allocative Efficiency and Financial Sustainability Study
Keywords
men who have sex with men

Citation

Cheikh,Nejma; Fraser-Hurt,Nicole; Prestidge,Marelize; Haacker,Markus; Karamoko,Djibrilla; Masaki,Emiko.

Niger's HIV Response : Targeted Investments for a Healthy Future - Findings from the HIV Allocative Efficiency and Financial Sustainability Study (English). Washington, DC : World Bank Group. http://documents.worldbank.org/curated/en/967321468098047095

Niger's HIV Response : Targeted Investments for a Healthy Future - Findings from the HIV Allocative Efficiency and Financial Sustainability Study (English)

DETAILS

Citation

RELATED LINKS

SUBSCRIBE TO EMAIL ALERTS